To learn more about the New Canaan Urgent Assessment Program, visit its webpage.

Virtual Grand Rounds: Pharmacological Management of Adolescent Depression: Evidence-Based and Emerging Treatments

Presented by:

Michael Bloch, MD

Associate Professor

Yale School of Medicine

We will discuss the significant public health burden associated with pediatric depression and related conditions. First-line treatments for pediatric depression as well as their current evidence-base will then be discussed. Treatment-resistant depression will be defined in adolescents and then we will discuss the evidence behind commonly used pharmacological strategies for adolescents with TRD and their current evidence base. We will lastly discuss data on emerging treatments for adolescent depression including ketamine, ECT and rTMS.

   Educational Objectives

As a result of participating in this activity, learners should be able to:

  1. Describe the substantial health burden associated with pediatric depression and suicidality
  2. Name current evidence-based treatments for pediatric depression
  3. Describe the current evidence base for pharmacological and interventional treatment strategies for treatment-resistant depression in youths

Register

 After registering, you will receive a confirmation email containing information about joining the Zoom webinar.

Accreditation Statement: Silver Hill Hospital is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians.

Designation Statement: Silver Hill Hospital designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NASW/Connecticut Statement: This program has been approved for 1.5 Continuing Education Credit Hours by the National Association of Social Workers, CT and meets the continuing education criteria for CT Social Work Licensure renewal. Approval also meets the continuing education criteria for CT LMFTs, LPCs, and licensed psychologists.

New York Social Worker Statement: Silver Hill Hospital is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0728. This program is approved for 1.5 contact hours.

New York Psychologist Statement: Silver Hill Hospital is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0227.  This program is approved for 1.5 contact hours.

Speaker Disclosure:  Dr. Bloch provides research support to Janssen Pharmaceuticals, Emalex Biosciences, Neurocrine Biosciences. All relevant financial relationships with an ACCME defined commercial interest have been mitigated and there are no conflicts of interest or bias.

No planners of this activity have indicated a relevant financial relationship with an ACCME defined commercial interest.